PMID- 23006534 OWN - NLM STAT- MEDLINE DCOM- 20130401 LR - 20240321 IS - 1479-5876 (Electronic) IS - 1479-5876 (Linking) VI - 10 DP - 2012 Sep 24 TI - Effects of helium and air inhalation on the innate and early adaptive immune system in healthy volunteers ex vivo. PG - 201 LID - 10.1186/1479-5876-10-201 [doi] AB - BACKGROUND: Helium inhalation protects myocardium, brain and endothelium against ischemia/reperfusion injury in animals and humans, when applied according to specific "conditioning" protocols. Before widespread use of this "conditioning" agent in clinical practice, negative side effects have to be ruled out. We investigated the effect of prolonged helium inhalation on the responsiveness of the human immune response in whole blood ex vivo. METHODS: Male healthy volunteers inhaled 30 minutes heliox (79%He/21%O(2)) or air in a cross over design, with two weeks between measurements. Blood was withdrawn at T0 (baseline), T1 (25 min inhalation) and T2-T5 (1, 2, 6, 24 h after inhalation) and incubated with lipopolysaccharide (LPS), lipoteichoic acid (LTA), T-cell stimuli anti-CD3/ anti-CD28 (TCS) or RPMI (as control) for 2, 4 and 24 hours or not incubated (0 h). An additional group of six volunteers inhaled 60 minutes of heliox or air, followed by blood incubation with LPS and RPMI. Tumor necrosis factor-alpha (TNF-alpha), interleukin-1beta (IL-1beta), interleukin-6 (IL-6), interleukin-8 (IL-8), interferon-gamma (IFN-gamma) and interleukin-2 (IL-2) was analyzed by cytometric bead array. Statistical analysis was performed by the Wilcoxon test for matched samples. RESULTS: Incubation with LPS, LTA or TCS significantly increased TNF-alpha, IL-1beta, IL-6, IL-8, IFN-gamma and IL-2 in comparison to incubation with RPMI alone. Thirty min of helium inhalation did not influence the amounts of TNF-alpha, IL-1beta, IL-6, IL-8, IFN-gamma and IL-2 in comparison to air. Sixty min of helium inhalation did not affect cytokine production after LPS stimulation. CONCLUSIONS: We conclude that 79% helium inhalation does not affect the responsiveness of the human immune system in healthy volunteers. TRIAL REGISTRATION: Dutch Trial Register: http://www.trialregister.nl/ NTR2152. FAU - Oei, Gezina T M L AU - Oei GT AD - Laboratory of Experimental Intensive Care and Anesthesiology, Academic Medical Centre, University of Amsterdam, The Netherlands. FAU - Smit, Kirsten F AU - Smit KF FAU - vd Vondervoort, Djai AU - vd Vondervoort D FAU - Brevoord, Daniel AU - Brevoord D FAU - Hoogendijk, Arjan AU - Hoogendijk A FAU - Wieland, Catharina W AU - Wieland CW FAU - Hollmann, Markus W AU - Hollmann MW FAU - Preckel, Benedikt AU - Preckel B FAU - Weber, Nina C AU - Weber NC LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20120924 PL - England TA - J Transl Med JT - Journal of translational medicine JID - 101190741 RN - 0 (Cytokines) RN - 206GF3GB41 (Helium) SB - IM MH - *Air MH - Cytokines/metabolism MH - Helium/*administration & dosage MH - Humans MH - *Immunity, Innate MH - Inhalation Exposure MH - Male MH - Reference Values PMC - PMC3495766 EDAT- 2012/09/26 06:00 MHDA- 2013/04/02 06:00 PMCR- 2012/09/24 CRDT- 2012/09/26 06:00 PHST- 2012/08/06 00:00 [received] PHST- 2012/09/19 00:00 [accepted] PHST- 2012/09/26 06:00 [entrez] PHST- 2012/09/26 06:00 [pubmed] PHST- 2013/04/02 06:00 [medline] PHST- 2012/09/24 00:00 [pmc-release] AID - 1479-5876-10-201 [pii] AID - 10.1186/1479-5876-10-201 [doi] PST - epublish SO - J Transl Med. 2012 Sep 24;10:201. doi: 10.1186/1479-5876-10-201.